共 50 条
[44]
A reality check of the accelerated approval of immune-checkpoint inhibitors
[J].
Nature Reviews Clinical Oncology,
2019, 16
:656-658
[45]
Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
[J].
ONCOTARGETS AND THERAPY,
2020, 13
:11725-11740
[46]
Are immune-checkpoint inhibitors immunosuppressive to hepatitis B virus?
[J].
Hepatology International,
2022, 16
:482-483
[48]
Economic sustainability of immune-checkpoint inhibitors: the looming threat
[J].
Nature Reviews Clinical Oncology,
2018, 15
:721-722